Could GLP-1s help treat opioid use disorder? Vanderbilt Health study now enrolling

The study, Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder (TAB), is a double-blind, randomized, placebo-controlled trial conducted through the National Institute on Drug Abuse’s Clinical Trials Network.

A first aid kit from Firefly Program for every new mother — with naloxone inside

The Tennessee Department of Health, through the Opioid Abatement Council Community Grant program, recently awarded $1.2M to The Naloxone Project, a nonprofit dedicated to patient-centric care for individuals with opioid use disorder.

Firefly program ice cream social to be at Jeni’s Splendid Ice Creams in 12 South, June 4

Weekly buprenorphine injection proves more effective for pregnant women with opioid use disorder

Vanderbilt Health’s Firefly program continues to lead the way in caring for pregnant women with substance use disorder.

Naloxone distribution box now available at One Hundred Oaks Pharmacy

Naloxone should be given to any person who shows signs of an opioid overdose or when an overdose is suspected.

Neurodevelopmental care initiative supports infants and young children exposed to opioids in utero

SHINE program offers neurodevelopmental care embedded within a medical home for infants and young children with neonatal opioid exposures.